Post job

Theravance Biopharma's revenue is $64.4 million.

What is Theravance Biopharma's revenue?

Theravance Biopharma's annual revenue is $64.4M. Zippia's data science team found the following key financial metrics about Theravance Biopharma after extensive research and analysis.
  • Theravance Biopharma's revenue growth from 2023 to 2024 is 12.12%.
  • Theravance Biopharma has 363 employees, and the revenue per employee ratio is $177,358.
  • Theravance Biopharma's peak quarterly revenue was $18.8M in 2024(q4).
  • Theravance Biopharma peak revenue was $64.4M in 2024.
  • Theravance Biopharma annual revenue for 2024 was 64.4M, 12.12% growth from 2023.

On this page

Most recent quarter revenue
$18.8M (Q4'2024)
Company most recent quarter revenue
Peak revenue
$64.4M (2024)
Company peak revenue
Revenue / employee
$177,358
Company revenue / employee

Zippi applies for you, and finds you a job.

Floating question marks illustration
Most recent quarter revenue
$18.8M (Q4'2024)
Company most recent quarter revenue
Peak revenue
$64.4M (2024)
Company peak revenue
Revenue / employee
$177,358
Company revenue / employee

Theravance Biopharma financial information

CEORick E. Winningham
IndustryCommercial & Professional Services
Company TypePublic
Employees Number363
Date Founded2014
HeadquartersSouth San Francisco, California
Number of Locations2
Revenue$64.4M
Net Income$872,132,000
Tax Rate-0.3%
Total Assets$607,400,000
TickerTBPH

Theravance Biopharma jobs you might like

Theravance Biopharma financing

Theravance Biopharma received early financing of $55.0M on 2015-10-26.

SeriesRound sizeDate
Post-IPO Equity - Theravance Biopharma$55M10/2015

Theravance Biopharma investors

InvestorsSecurity type
Woodford Investment ManagementPost-IPO Equity - Theravance Biopharma

Theravance Biopharma competitors

Theravance Biopharma's top competitor, Array BioPharma, earned an annual revenue of $173.8M.

Theravance Biopharma's smallest competitor is Arena Pharmaceuticals with revenue of $54.0K last year.

Company nameAverage salaryRevenueEmployee sizeJob openings
Array BioPharma-$173.8M298-
Matinas BioPharma-$1.1M20-
celleng-tech-$200,0008-
Genentech-$166.9M13,638-
Genocea--59-
Abbott-$42.0B109,000-
Metabolix-$9.1M50-
triusrx.com-$27.2M50-
Arena Pharmaceuticals-$54,000194-
Cellerant Therapeutics-$3.8M7-

Theravance Biopharma revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of Theravance Biopharma, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Theravance Biopharma. The employee data is based on information from people who have self-reported their past or current employments at Theravance Biopharma. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Theravance Biopharma. The data presented on this page does not represent the view of Theravance Biopharma and its employees or that of Zippia.

Theravance Biopharma may also be known as or be related to Theravance, Theravance Biopharma, Theravance Biopharma Inc, Theravance Biopharma Us, Inc. and Theravance Biopharma, Inc.